デフォルト表紙
市場調査レポート
商品コード
1555714

筋肉内薬剤希釈装置市場：薬物タイプ別、タイプ別、形態別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Intramuscular Drug Dilutor Market, By Drug Type, By Type, By Form, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 381 Pages
納期
2～3営業日
カスタマイズ可能
筋肉内薬剤希釈装置市場：薬物タイプ別、タイプ別、形態別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年08月23日
発行: AnalystView Market Insights
ページ情報: 英文 381 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

レポートハイライト

筋肉内薬剤希釈装置の市場規模は2023年に11億2,123万米ドルとなり、2024年から2032年にかけてCAGR11.8%で拡大

筋肉内薬剤希釈装置市場-市場力学

慢性疾患の増加が筋肉内薬剤希釈装置の需要を促進

慢性疾患の増加は、筋肉内薬剤希釈装置の需要を大きく押し上げています。これらの機器は、糖尿病や関節リウマチのような症状を持つ患者の正確な薬剤投与を確実にするためです。世界保健機関（WHO）によると、慢性疾患は世界の死因の71％を占めており、正確な薬物送達システムの必要性が浮き彫りになっています。米国疾病予防管理センター（CDC）の報告によると、米国成人の40%以上が慢性疾患に罹患しており、信頼性の高い薬剤希釈ソリューションの需要がさらに高まっています。このような患者数の増加により、複雑な治療レジメンを効果的に管理するための高度な希釈器が必要となり、市場の成長と技術革新が促進されています。

筋肉内薬剤希釈装置市場-主要インサイト

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約11.8%のCAGRで毎年成長すると推定されています。

薬剤タイプ別では、ワクチンが2023年に最大の市場シェアを示すと予測されています。

タイプ別では、自動希釈器が2023年の主要タイプです。

剤形別では、2023年にはマルチドーズダイリューターが主要タイプでした。

地域別では、北米が2023年に収益でリードしました。

筋肉内薬剤希釈装置市場-セグメンテーション分析：

筋肉内薬剤ダイリューターの世界市場は、薬剤タイプ、タイプ、形態、用途、地域に基づいて区分されます。

市場は薬剤タイプに基づいて4つのカテゴリーに分けられます：ワクチン、ホルモン、抗生物質、生物製剤です。ワクチンは予防接種プログラムで広く使用されているため市場をリードし、次いでホルモンは様々な治療に不可欠です。次いで感染症治療に不可欠な抗生物質がランクインし、生物製剤は成長しているとはいえ、他と比べると小さなセグメントです。

市場はタイプによって2つのカテゴリーに分けられる：手動希釈器と自動希釈器です。自動希釈器はその精度と使いやすさから好まれ、次いで手動希釈器が自動化が不可能な場合によく使用されます。自動システムは希釈プロセスを合理化し、薬剤投与の正確性と効率を高めます。

筋肉内薬剤希釈装置市場-地理的洞察

北米は、高度な医療施設と慢性疾患の罹患率の高さに牽引されて市場をリードしており、病院では正確な薬剤投与のためにこうした機器の導入が進んでいます。欧州がこれに続き、医療制度が患者の安全性と薬剤投与の正確性を重視しているドイツや英国などが大きく貢献しています。アジア太平洋地域は、中国やインドのような国々における医療インフラの拡大と慢性疾患率の上昇により、急速な成長を遂げています。さらに、中南米と中東・アフリカは新興市場であり、医療アクセスの改善と医療技術への投資の増加が市場の発展を促進しています。治療の有効性と安全性を高めることが世界的に重視されていることが、これらの多様な地域での採用を促進しており、市場のダイナミックな地域情勢を浮き彫りにしています。

筋肉内薬剤希釈装置市場-競争状況：

バクスターインターナショナル、B. Braun Melsungen、テルモなどの大手企業は、精度、使いやすさ、既存の医療システムとの統合に重点を置いた先進的な希釈器デバイスで市場を席巻しています。バクスター・インターナショナルのドラッグデリバリーシステムに関する専門知識と、B.ブラウンの幅広い製品ポートフォリオが主要な競争優位性です。また、テルモは技術革新とユーザー中心の設計を重視しており、同市場において強力な地位を築いています。新興企業や地域メーカーも、費用対効果の高いソリューションや特定の医療環境に合わせた製品を提供することで進出しています。各社が技術力の強化と世界展開の拡大を目指す中、戦略的提携、合併、買収が盛んに行われています。このような競争環境は、製品の機能と性能の継続的な進歩を促し、市場全体と医療成果に利益をもたらしています。

目次

第1章 筋肉内薬剤希釈装置市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 筋肉内薬剤希釈装置の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 筋肉内薬剤希釈装置産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 筋肉内薬剤希釈装置市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 筋肉内薬剤希釈装置市場情勢

  • 筋肉内薬剤希釈装置市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 筋肉内薬剤希釈装置市場- 薬物タイプ別

  • 概要
    • セグメントシェア分析
    • ワクチン
    • ホルモン
    • 抗生物質
    • 生物学的製剤

第8章 筋肉内薬剤希釈装置市場- タイプ別

  • 概要
    • セグメントシェア分析
    • 手動希釈装置
    • 自動希釈装置

第9章 筋肉内薬剤希釈装置市場- 形態別

  • 概要
    • セグメントシェア分析
    • シングルドーズ希釈装置
    • マルチドーズ希釈装置

第10章 筋肉内薬剤希釈装置市場- 用途別

  • 概要
    • セグメントシェア分析
    • 定期予防接種
    • 緊急治療
    • 慢性疾患管理
    • 急性疾患

第11章 筋肉内薬剤希釈装置市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- 筋肉内薬剤希釈装置業界

  • 競合ダッシュボード
  • 企業プロファイル
    • AbbVie Inc.
    • Amgen Inc.
    • Baxter International Inc.
    • Becton, Dickinson and Company（BD）
    • Braun Melsungen AG
    • Fresenius Kabi AG
    • GlaxoSmithKline plc
    • Johnson &Johnson
    • Medtronic plc
    • Merck &Co., Inc.
    • Pfizer Inc.
    • Roche Diagnostics
    • Sanofi SA
    • Sartorius AG
    • Terumo Corporation
    • Vetter Pharma International GmbH
    • Others

第13章 アナリストの全方位展望

目次
Product Code: ANV3691

REPORT HIGHLIGHT

The Intramuscular Drug Dilutor Market size was valued at USD 1,121.23 million in 2023, expanding at a CAGR of 11.8% from 2024 to 2032.

The Intramuscular Drug Dilutor Market focuses on devices used to dilute medications for intramuscular injection, ensuring accurate dosing and enhanced patient safety. The growing prevalence of chronic diseases and the increasing need for precise drug administration are bolstering market demand, with over 40% of hospitals in the U.S. adopting these devices. However, challenges such as high costs and the need for specialized training to use these systems may limit growth. Opportunities lie in the development of more user-friendly and cost-effective dilutors, as well as expanding applications in emerging markets where healthcare infrastructure is improving. Advancements in smart technology are poised to revolutionize this market by integrating automated dilution processes for enhanced accuracy.

Intramuscular Drug Dilutor Market- Market Dynamics

Rising Chronic Diseases Fuel the Demand for Intramuscular Drug Dilutors

The rising prevalence of chronic diseases is significantly driving the demand for intramuscular drug dilutors, as these devices ensure precise medication administration for patients with conditions such as diabetes and rheumatoid arthritis. According to the World Health Organization (WHO), chronic diseases account for 71% of global deaths, highlighting the need for accurate drug delivery systems. The Centers for Disease Control and Prevention (CDC) reports that more than 40% of U.S. adults suffer from chronic conditions, further increasing the demand for reliable drug dilution solutions. This growing patient population necessitates advanced dilutors to manage complex treatment regimens effectively, thereby propelling market growth and innovation.

Intramuscular Drug Dilutor Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.8% over the forecast period (2024-2032)

Based on Drug Type segmentation, Vaccines were predicted to show maximum market share in the year 2023

Based on Type segmentation, Automatic Dilutors was the leading type in 2023

Based on Form segmentation, Multi-Dose Dilutors were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Intramuscular Drug Dilutor Market- Segmentation Analysis:

The Global Intramuscular Drug Dilutor Market is segmented based on Drug Type, Type, Form, Application, and Region.

The market is divided into four categories based on Drug Type: Vaccines, Hormones, Antibiotics, and Biologics. Vaccines lead the market due to their widespread use in immunization programs, followed by hormones, which are crucial for various therapies. Antibiotics rank next, essential for infection treatment, while biologics, though growing, occupy a smaller segment compared to the others.

The market is divided into two categories based on Type: Manual Dilutors and Automatic Dilutors. Automatic dilutors are preferred due to their precision and ease of use, followed by manual dilutors, which are often used where automation is not feasible. Automatic systems streamline the dilution process, enhancing accuracy and efficiency in drug administration.

Intramuscular Drug Dilutor Market- Geographical Insights

North America leads the market, driven by advanced healthcare facilities and a high incidence of chronic diseases, with hospitals increasingly adopting these devices for precise drug administration. Europe follows closely, with significant contributions from countries like Germany and the UK, where healthcare systems emphasize patient safety and accuracy in drug delivery. The Asia-Pacific region is experiencing rapid growth due to expanding healthcare infrastructure and rising chronic disease rates in countries like China and India. Additionally, Latin America and the Middle East & Africa are emerging markets, where improving healthcare access and increasing investments in medical technology are fostering market development. The global emphasis on enhancing treatment efficacy and safety is driving adoption across these diverse regions, highlighting the market's dynamic regional landscape.

Intramuscular Drug Dilutor Market- Competitive Landscape:

Leading companies such as Baxter International, B. Braun Melsungen, and Terumo Corporation dominate the landscape with their advanced dilutor devices, focusing on precision, ease of use, and integration with existing medical systems. Baxter International's expertise in drug delivery systems and B. Braun's broad product portfolio are key competitive advantages. Additionally, Terumo's emphasis on technological innovation and user-centric design positions it strongly in the market. Emerging players and regional manufacturers are also making inroads by offering cost-effective solutions and tailored products for specific healthcare settings. Strategic collaborations, mergers, and acquisitions are prevalent as companies seek to enhance their technological capabilities and expand their global reach. This competitive environment drives continuous advancements in product features and performance, benefiting the overall market and healthcare outcomes.

Recent Developments:

In February 2021, Biogen's PLEGRIDY (peginterferon beta-1a) received FDA approval for intramuscular administration, offering relapsing MS patients a proven therapy with reduced injection site reactions. The approval expands Biogen's MS portfolio, providing more options during the COVID-19 pandemic.

In January 2022, Hikma Pharmaceuticals launched Diazepam Injection USP in a single-dose prefilled syringe. This ready-to-use formulation simplifies the administration of the benzodiazepine medication for acute repetitive seizures and status epilepticus in healthcare settings.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INTRAMUSCULAR DRUG DILUTOR MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • AbbVie Inc.
  • Amgen Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company (BD)
  • Braun Melsungen AG
  • Fresenius Kabi AG
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Medtronic plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Roche Diagnostics
  • Sanofi S.A.
  • Sartorius AG
  • Terumo Corporation
  • Vetter Pharma International GmbH
  • Others

GLOBAL INTRAMUSCULAR DRUG DILUTOR MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2019 - 2032

  • Vaccines
  • Hormones
  • Antibiotics
  • Biologics

GLOBAL INTRAMUSCULAR DRUG DILUTOR MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Manual Dilutors
  • Automatic Dilutors

GLOBAL INTRAMUSCULAR DRUG DILUTOR MARKET, BY FORM- MARKET ANALYSIS, 2019 - 2032

  • Single-Dose Dilutors
  • Multi-Dose Dilutors

GLOBAL INTRAMUSCULAR DRUG DILUTOR MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Routine Immunization
  • Emergency Treatment
  • Chronic Disease Management
  • Acute Conditions

GLOBAL INTRAMUSCULAR DRUG DILUTOR MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Intramuscular Drug Dilutor Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Intramuscular Drug Dilutor Market Snippet by Drug Type
    • 2.1.2. Intramuscular Drug Dilutor Market Snippet by Type
    • 2.1.3. Intramuscular Drug Dilutor Market Snippet by Form
    • 2.1.4. Intramuscular Drug Dilutor Market Snippet by Application
    • 2.1.5. Intramuscular Drug Dilutor Market Snippet by Country
    • 2.1.6. Intramuscular Drug Dilutor Market Snippet by Region
  • 2.2. Competitive Insights

3. Intramuscular Drug Dilutor Key Market Trends

  • 3.1. Intramuscular Drug Dilutor Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Intramuscular Drug Dilutor Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Intramuscular Drug Dilutor Market Opportunities
  • 3.4. Intramuscular Drug Dilutor Market Future Trends

4. Intramuscular Drug Dilutor Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Intramuscular Drug Dilutor Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Intramuscular Drug Dilutor Market Landscape

  • 6.1. Intramuscular Drug Dilutor Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Intramuscular Drug Dilutor Market - By Drug Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Type, 2023 & 2032 (%)
    • 7.1.2. Vaccines
    • 7.1.3. Hormones
    • 7.1.4. Antibiotics
    • 7.1.5. Biologics

8. Intramuscular Drug Dilutor Market - By Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 8.1.2. Manual Dilutors
    • 8.1.3. Automatic Dilutors

9. Intramuscular Drug Dilutor Market - By Form

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Form, 2023 & 2032 (%)
    • 9.1.2. Single-Dose Dilutors
    • 9.1.3. Multi-Dose Dilutors

10. Intramuscular Drug Dilutor Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2. Routine Immunization
    • 10.1.3. Emergency Treatment
    • 10.1.4. Chronic Disease Management
    • 10.1.5. Acute Conditions

11. Intramuscular Drug Dilutor Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Intramuscular Drug Dilutor Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Intramuscular Drug Dilutor Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Intramuscular Drug Dilutor Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Intramuscular Drug Dilutor Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Intramuscular Drug Dilutor Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Intramuscular Drug Dilutor Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. AbbVie Inc.
    • 12.2.2. Amgen Inc.
    • 12.2.3. Baxter International Inc.
    • 12.2.4. Becton, Dickinson and Company (BD)
    • 12.2.5. Braun Melsungen AG
    • 12.2.6. Fresenius Kabi AG
    • 12.2.7. GlaxoSmithKline plc
    • 12.2.8. Johnson & Johnson
    • 12.2.9. Medtronic plc
    • 12.2.10. Merck & Co., Inc.
    • 12.2.11. Pfizer Inc.
    • 12.2.12. Roche Diagnostics
    • 12.2.13. Sanofi S.A.
    • 12.2.14. Sartorius AG
    • 12.2.15. Terumo Corporation
    • 12.2.16. Vetter Pharma International GmbH
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us